We are live on ! Find out more
IMA

ImageneBio Inc
IMA

39 hedge funds and large institutions have $86.2M invested in ImageneBio Inc in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

24% more capital invested

Capital invested by funds: $69.8M → $86.2M (+$16.4M)

15% more funds holding

Funds holding: 34 → 39 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.29% less ownership

Funds ownership: 6.04% → 5.74% (-0.29%)

Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
15
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$2.55M
2
O
OrbiMed
New York
+$966K
3
Millennium Management
Millennium Management
New York
+$378K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$152K
5
Jane Street
Jane Street
New York
+$147K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$7.56M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.57M
3
OMC
Oasis Management Company
Cayman Islands
-$372K
4
E
Ergoteles
New York
-$46.8K
5
TRCT
Tower Research Capital (TRC)
New York
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$17.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$11.4M -$1.57M -34,266 -11%
O
3
OrbiMed
New York
$11M +$966K +21,019 +9%
BI
4
BVF Inc
California
$10.9M +$2.55M +55,508 +27%
OFM
5
Omega Fund Management
Massachusetts
$7.76M – – –
CA
6
CHI Advisors
New York
$5.73M +$90K +1,958 +1%
Verition Fund Management
7
Verition Fund Management
Connecticut
$5.51M +$59.6K +1,297 +1%
AG
8
Artal Group
Luxembourg
$5.35M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.45M +$73.1K +1,590 +2%
LCM
10
Laurion Capital Management
New York
$1.83M – – –
BlackRock
11
BlackRock
New York
$1.06M +$6.99K +152 +0.6%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$837K +$24.1K +524 +3%
Barclays
13
Barclays
United Kingdom
$683K -$5.24K -114 -0.7%
Citadel Advisors
14
Citadel Advisors
Florida
$621K -$7.56M -164,587 -92%
BCM
15
Bridgeway Capital Management
Texas
$396K +$95.7K +2,083 +28%
DCM
16
DAFNA Capital Management
California
$390K -$36.7K -799 -8%
Millennium Management
17
Millennium Management
New York
$376K +$378K +8,223 +967%
Ensign Peak Advisors
18
Ensign Peak Advisors
Utah
$312K – – –
State Street
19
State Street
Massachusetts
$207K +$35.3K +767 +18%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$143K +$48.9K +1,063 +44%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$137K +$152K +3,311 New
CIC
22
Cornercap Investment Counsel
Georgia
$136K +$38.3K +833 +34%
Jane Street
23
Jane Street
New York
$132K +$147K +3,193 New
Goldman Sachs
24
Goldman Sachs
New York
$121K +$135K +2,933 New
Northern Trust
25
Northern Trust
Illinois
$106K +$14.1K +306 +14%
1
2

IMA Hedge Fund Activity: Q1 2023 in Review

39 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2023, worth a combined $86.2M — up 24% from $69.8M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IMA positions and 2 closed out — a net gain of 5 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was BVF Inc, adding an estimated $2.55M. The largest seller was Citadel Advisors, cutting an estimated $7.56M.

  • 39 institutional investors held ImageneBio Inc (IMA) as of Q1 2023, up from 34 in Q4 2022.
  • Funds reported $86.2M of ImageneBio Inc stock for Q1 2023, up 24% quarter-over-quarter.
  • 7 funds opened new ImageneBio Inc positions in Q1 2023 and 2 closed out, a net change of +5 holders.
  • The largest ImageneBio Inc buyer in Q1 2023 was BVF Inc, an estimated $2.55M added.
  • The largest ImageneBio Inc seller in Q1 2023 was Citadel Advisors, an estimated $7.56M sold.

Based on aggregated 13F filings for Q1 2023.